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Edited by Robert BaroukiAbstract Many aspects of physiology and behavior in organ-
isms from bacteria to man are subjected to circadian regulation.
Indeed, the major function of the circadian clock consists in the
adaptation of physiology to daily environmental change and the
accompanying stresses such as exposition to UV-light and food-
contained toxic compounds. In this way, most aspects of xenobi-
otic detoxiﬁcation are subjected to circadian regulation. These
phenomena are now considered as the molecular basis for the
time-dependence of drug toxicities and eﬃcacy. However, there
is now evidences that these toxic compounds can, in turn, regu-
late circadian gene expression and thus inﬂuence circadian
rhythms. As food seems to be the major regulator of peripheral
clock, the possibility that food-contained toxic compounds par-
ticipate in the entrainment of the clock will be discussed.
 2007 Federation of European Biochemical Societies.
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Virtually all light-sensitive organisms from cyanobacteria to
humans show rhythmic regulation of many aspects of physiol-
ogy and behavior. The cycles with a period of approximately
24 h are considered to be circadian, derived from the Latin
words circa diem (meaning about a day). It has been recently
suggested that the evolution of circadian clock in the early
metazoan period was to avoid genotoxic UV-light [1]. Primi-
tive marine organisms have used blue-light receptors (e.g.,
photolyase and cryptochromes) to avoid UV-rich sunlight by
moving to deeper sea levels. These blue-light receptors later
evolved to become coupled to a circadian oscillator that could
anticipate this up-and-down migratory behavior. In mammals,
this behavior has evolved to include the anticipation of daily
food availability and predator threat.
At a physiological level, the main task of the circadian clock
is the optimization of metabolism and energy utilization for
sustaining life processes in the organism. In this context, many
aspects of the physiological adaptation to daily food intake,*Corresponding author. Address: CNRS, Institut de Ge´ne´tique
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doi:10.1016/j.febslet.2007.04.009metabolism and detoxiﬁcation are regulated in an anticipatory
fashion by the circadian clock [2]. For example, rest and activ-
ity cycles, heart rate, blood pressure, bile and urine produc-
tion, drug metabolism and transport in liver and intestine as
well as endocrine functions are all subjected to daily ﬂuctua-
tions. The mammalian timing system is organized in a hierar-
chical manner with a central pacemaker located in the
suprachiasmatic nucleus (SCN) of the hypothalamus which
synchronizes in a coordinated fashion cellular circadian oscil-
lators present in all peripheral organs by cyclic neuronal and
humoral signals emanating directly or indirectly from the
SCN [3]. At a molecular level, there is no diﬀerence in the cir-
cadian clock of SCN neurons and peripheral cells [4]. How-
ever, there is a major distinction in their synchronization:
SCN neurons phase is engendered by light-dark cycles per-
ceived by the retina [5], whereas peripheral oscillators phase
is adjusted by chemical zeitgebers, like for example signals gen-
erated by feeding-fasting rhythms [6,7]. In this context, the
time-dependent inactivation of food-contained toxic com-
pounds is among the important function of the circadian
clock. As a consequence, the circadian pharmacokinetics and
pharmacodynamics that modulate drug eﬀectiveness and toxic-
ity are a manifestation of the circadian regulation of xenobi-
otic detoxiﬁcation and could have important clinical
applications since they allow treatment modiﬁcation in order
to increase drug eﬀects or decrease side eﬀects [8] (see Fig. 1).
In mammals, the xenobiotic defense system involved in
drug metabolism is composed of three groups of proteins
assuming distinct functions [9]. The phase I group contains
the microsomal P450 cytochrome super-family enzymes
with oxidase, reductase or hydroxylase activities. Phase II,
or conjugating enzymes, comprises sulfotransferases (SULT),
UDP-glucuronotransferases (UGT), NAD(P)H:quinine
oxidoreductases (NQO), epoxide hydrolases (EPH), glutathi-
one-S-transferases (GSH), and N-acetyltransferases (NAT).
Conjugation help to make lipophilic compounds hydrophilic
enough to subsequently control and facilitate their excretion
into bile, faeces and/or urine by the transporters or phase
III group, like multidrug resistance-associated proteins
(MRP) or P-glycoprotein (P-gp), which serve as barriers to
limit the penetration of xenobiotics. In addition, some other
proteins like the Aminolevulinic acid synthase (ALAS1) and
the P450 oxidoreductase (POR) regulate the activity of most
of the phase I enzymes. ALAS1 is the rate-limiting enzyme
in heme synthesis, the prosthetic group of all cytochrome
P450 enzymes. Since monooxygenase reaction requires elec-
trons that are extracted from NAD(P)H and transferred viablished by Elsevier B.V. All rights reserved.
Fig. 1. Hierarchical organization of the circadian detoxiﬁcation
machinery. The light/dark cycle resets the activity of the master
pacemaker located in the SCN via ganglionar cells of the retina. The
SCN then provides timing cues that will synchronize other slave
oscillators located in peripheral tissues. Peripheral oscillators can also
be reset by changing the feeding rhythm. As a result, peripheral organs
display synchronized orchestration of their individual detoxiﬁcation
processes which lead to circadian detoxiﬁcation of the organism.
Fig. 2. Simpliﬁed model of the mammalian circadian oscillator. The
molecular mammalian circadian clock is based on molecular feedback
loops with a positive limb (BMAL1 heterodimer) and a negative limb
(PER/CRY complex) that are interconnected via the nuclear orphan
receptor REV-ERBa. This core oscillator, in addition to the core
oscillator-regulated circadian transcription factors REV-ERBa and
PARbZip, contribute to the generation of circadian clock controlled
genes which participate in the generation of circadian physiology and
behavior.
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P450 enzymes, expression of cytochrome P450 enzymes,
ALAS1 and POR are coordinated.
Interestingly, genome-wide analysis of liver transcriptome
revealed that proteins of the phase I–III groups of detoxiﬁca-
tion as well as ALAS1 and POR are expressed in a circadian
fashion [10–13]. It is thus conceivable that the circadian
expression of proteins involved in xenobiotic detoxiﬁcation is
responsible for the daytime-dependent drug metabolism that
modulates drug eﬀectiveness and toxicity.2. Control of circadian genes expression
Studies in mice have shown that the circadian rhythm in
gene expression is generated by a molecular oscillator, presents
in all cells of the animal, driven by transcriptional and post-
transcriptional feedback loop involving a positive and a
negative limb. The positive limb consists of the bHLH-PAS
transcription factor BMAL1 and its dimerization partners
CLOCK or NPAS2. This heterodimer activates the transcrip-
tion of the members of the negative limb cryptochrome (Cry)
and period (Per). As a consequence, CRY and PER accumu-
late until they reach a treshold level that will allow them to
form complexes to attenuate the transcriptional activity of
the BMAL1 heterodimer and thereby autorepress their own
genes. Subsequently, this leads to a decrease of the CRY-
PER complex now unable to perform the autorepression anda new cycle of Cry and Per transcription can start. The same
activators and repressors drive the circadian expression of
the orphan nuclear receptor REV-ERBa which periodically
represses Bmal1 expression and then contributes to the
circadian expression of Bmal1 (see Fig. 2 and for more detailed
reviews, see Ref. [14]).
In addition to the core oscillator genes, the circadian clock
drives numerous output genes to translate circadian rhythm
into physiological and behavioral events. These output genes
comprise transcription factors directly controlled by the core
oscillator [15,16] that repress (REV-ERBa) [17] or activate
(PARbZip) [18,19] their target gene. This transcription factors
cascade thus orchestrates the circadian genes expression
involved in the daytime-dependent xenobiotic detoxiﬁcations.
Transcriptome proﬁling in several tissues indicated that
2–10% of the genes are transcribed in a circadian manner
[10–13]. The transcriptional circuitry leading to circadian
detoxiﬁcation is resumed in Fig. 3 and will be described in
the next section.3. Circadian transcription factors and detoxiﬁcation
3.1. PARbZip transcription factors
Recent data suggests that the well-conserved transcription
factors of the PARbZip family play an important role in xeno-
biotic detoxiﬁcation. This family is composed of the three
members DBP (albumin site D-binding protein), TEF (thyro-
troph embryonic factor) and HLF (hepatocyte leukemia fac-
tor). These proteins bind DNA elements of the consensus
sequence 5 0-VTTAYGTAAY-3 0(where V is C, G or A, and
Y is C or T) as homo- or heterodimer [20]. They are expressed
under a robust circadian fashion in most organs, although the
Fig. 3. Transcriptional network controlling circadian detoxiﬁcation. The core oscillator control circadian expression of PARbZip transcription
factors which, in turn, control the expression of CAR and PPARa, but also Alas1 and P450 OxRed, to coordinate an important part of the circadian
xenobiotic detoxiﬁcation. In addition, this oscillator induces the circadian expression of AhR, contributing to another way of regulation of circadian
drug metabolism. Finally, the BMAL1-controlled circadian expression of SHP negatively modulates diﬀerent aspects of the xenobiotic response and
ampliﬁes the circadian regulation.
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small intestine [21]. Mice devoid of one or two PARbZip genes
show mild phenotypes. However, mice deﬁcient of all three
members suﬀer from a high juvenile mortality and a high adult
morbidity. The high mortality within the ﬁrst three months is
due to spontaneous and sound-induced seizures probably
caused by a defect in vitamin B6 metabolism. PARbZip-deﬁ-
cient mice have reduced level of pyridoxal phosphate (PLP),
the active form of vitamin B6 and a required coenzyme in-
volved in neurotransmitter synthesis. The gene coding for pyr-
idoxal kinase (Pdxk), that controls PLP synthesis, is under the
control of PARbZip transcription factors [19]. Despite the fact
that after three months the seizures decreased, the mice con-
tinue to present an important mortality since less than 20%
of them are still alive after one year. Moreover, PARbZip-deﬁ-
cient mice show signs of accelerated aging, such as cachexia,
lordokyphosis, and an absence of vigor. Transcriptome proﬁl-
ing using DNA microarray technology revealed that PARbZip
proteins control expression of many genes involved in xenobi-
otic detoxiﬁcation in liver and kidney [18]. These include genes
of the phase I (Cyp 2b, 2c and 2a), phase II (Ces3, Cml3,4,5,
GSTt1, a3) and phase III (ABCG2) group of detoxiﬁcation.
In addition, these proteins control the expression of ALAS1
and POR, two enzymes required for the activity of cytochrome
P450 enzymes.
Importantly, this study revealed that PARbZip transcription
factor control the circadian expression of the constitutive
androstane receptor (CAR), a key nuclear receptor involved
in xenobiotic detoxiﬁcation [22]. The consequence of the circa-
dian expression of CAR is a strong daytime-dependent induc-
tion of Cyp2b10 mRNA by phenobarbital in liver and small
intestine of wild-type mice, whereas PARbZip-deﬁcient mice
have a very low induction throughout the day. Moreover,
PARbZip-deﬁcient mice are highly susceptible to toxicity in-
duced by anticancer drugs. Therefore, it is possible that the
downregulation of some detoxiﬁcation genes in PARbZip tri-
ple knockout mice, including Cyp2b10, is a consequence of
the decreased expression of CAR but not a consequence of
the PARbZip deﬁciency per se. A recent study also revealeda role for clock genes in xenobiotic tolerability [23]. The
authors of this study show that mice with a Bmal1 null allele
or a mutation of the Clock gene displayed increased sensibility
to the toxic eﬀect of the anticancer agent cyclophosphamide,
whereas mice devoid of the two Cry genes were more resistant
to this eﬀect. As, at least for DBP, the expression of PARbZip
transcription factor is obliterated in Clock and Bmal1 knock-
out mice whereas this expression is constitutively high in
Cry-deﬁcient mice [16,24], it is conceivable that these eﬀects
reﬂect the level of PARbZip transcription factors, and of their
target genes.
3.2. Peroxisome proliferator activated receptor a
Peroxisome proliferator activated receptor alpha (PPARa) is
a nuclear receptor with a modular structure typical for steroid
receptor that binds to its cognate DNA elements as heterodi-
mers with the retinoid X receptor a (RXRa). PPARa is acti-
vated by compounds referred to as peroxisome proliferators,
such as lipid lowering ﬁbrates, phthalate-ester plasticizers, as
well as endogenous fatty acids. In response to these xenobiotic
toxic compounds, activated PPARa stimulates the expression
of phase I and II proteins such as Cyp4a [25] and UGT
[26,27]. If the major function of PPARa is to regulate lipid
and glucose homeostasis [28], the requirement of the PPARa
detoxiﬁcation pathway has been shown recently in the case
of toxic compounds contained in vegetal food such as sesame
grains [29].
Like other nuclear receptor, PPARa expression follows a
circadian rhythm at the mRNA and protein level [30]. It has
been suggested that this circadian expression is controlled
directly by BMAL1 and the molecular oscillator [31]. How-
ever, recent data suggests that lipid metabolism regulated by
PARbZip proteins seems to be also involved in the regulation
of PPARa expression (F. Gachon and Ueli Schibler, unpub-
lished results).
3.3. Aryl hydrocarbon receptor
The aryl hydrocarbon receptor (AhR), and its dimerization
partner AhR nuclear translocator (Arnt), belong to the
Table 1
Transcriptional regulation of circadian clock genes by xenobiotics
Circadian gene Drug Receptor Reference
BMal1 WY14643 PPARa Canaple et al. [53]
TCDD AhR Miller et al. [56]
Per1 FICZ AhR Mukai and Tischkau [57]
TCDD AhR Garrett and Gasiewicz [55]
Miller et al. [56]
Per2 TCDD AhR Garrett and Gasiewicz [55]
Fletcher et al. [33]
Per3 DEHP PPARa Currie et al. [54]
Cry1 FICZ AhR Mukai and Tischkau [57]
DEHP PPARa Currie et al. [54]
Cry2 FICZ AhR Mukai and Tischkau [57]
Dbp DEHP PPARa Currie et al. [54]
FICZ: 6-Formylindolo[3,2-b]carbazole.
TCDD: 2,3,7,8-Tetrachlorodibenzo-p-dioxin.
DEHP: Diethylhexylphtalate.
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factors. AhR/Arnt is activated by halogenated and polycyclic
aromatic hydrocarbons such as dioxin [32]. Once activated,
the AhR/Arnt heterodimer binds to its cognate DNA elements
and activate phase I and II enzymes such as Cyp1a and 1b,
UGT and NAD(P)H dehydrogenase [33,34]. AhR is known
to be modulated by a variety of dietary plant constituents pres-
ent in vegetables and fruits and is also one of the major eﬀec-
tors of the elimination of food-contained toxic compounds
[35]. Finally, and not surprisingly, AhR and Arnt show both
a diurnal expression in many organs including liver [36]. Inter-
estingly, Cyp1a1, the major AhR target gene, displays a circa-
dian expression suggesting a daily activation of the receptor by
food-contained toxic compounds [37].
3.4. Small heterodimer partner
The small heterodimer partner (SHP) is an atypical orphan
nuclear receptor containing the ligand-binding and dimeriza-
tion domains but lacking a DNA-binding domain. However,
SHP is located in the cell nucleus where it can interact with
many nuclear receptors and repress their transcriptional activ-
ity [38,39]. Interestingly, it has been shown that SHP is able to
interact and inhibit CAR [38,40], and also the related pregnane
X receptor (PXR) [41], two nuclear receptors that play a fun-
damental role in xenobiotic detoxiﬁcation. Importantly, these
two proteins are involved in the detoxiﬁcation of more than
60% of the drugs currently available and which display consid-
erable overlap in their action [42–44]. In addition, an interac-
tion between SHP and Arnt has been also described, despite
the fact that Arnt is not a nuclear receptor. This interaction
leads to the repression of the activated AhR/Arnt heterodimer
by SHP [45].
Since CAR, PXR and AhR constitute the major part of the
response to xenobiotics, the ability of SHP to interact and thus
subsequently inactivate them, identify SHP as a major repres-
sor of the xenobiotic detoxiﬁcation. Interestingly, it has been
shown that SHP mRNA showed a circadian expression pat-
tern in mouse liver, with a maximum of expression at the
end of the night which corresponds to the mouse active period
[46]. The authors speculate that this circadian expression is
directly controlled by the positive branch of the oscillator via
an interaction with the nuclear receptor LRH-1 (liver receptor
homolog-1), whereas the phase of SHP expression did not cor-
respond to the one of a classical BMAL1 target gene. In addi-
tion, this maximum time of expression correspond to the time
where CAR and AhR/Arnt start to show decreased expression
and also less transcriptional response to their normal activa-
tors. It seems that circadian SHP expression acts as a negative
modulator of the xenobiotic response and could play poten-
tially an important role in liver metabolism of toxic drugs by
amplifying the time-dependent response to toxic compounds.
Since SHP does still have the ability to bind a ligand, it will
be of interest to determine whether xenobiotics and/or their
metabolites can modulate SHP activity and therefore the end
of the xenobiotic response. Moreover, the recent characteriza-
tion of small molecules those are able to activate LRH-1 open
the possibility to study detoxiﬁcation modulation by nuclear
receptors in a circadian manner [47]. Intriguingly, SHP was
originally described as a CYP7A1 repressor, the limiting step
of the bile acid synthesis [48,49]. Bile acids are toxic com-
pounds detoxiﬁed by CAR among other nuclear receptorsand are involved in cholesterol metabolism [50]. Enzymes gen-
erating endogenous toxics are often call ‘‘Phase 0 enzymes’’ by
analogy with the phase I–III detoxiﬁcation systems (see
above). Based on the hopeful role of SHP, it was anticipated
that SHP and CYP7A1 rhythms will be strictly antiphasic.
However, SHP regulation by BMAL1/CLOCK and LRH-1
on one hand and CYP7A1 promoter trans-activation by
LRH-1 on the other hand seem to exclude a major role for
SHP in CYP7A1 bile acid-mediated negative feedback and
makes more likely that SHP will control CYP8B1 a down-
stream enzyme of the pathway. This can explain why SHP
transgenic mice that over express SHP do not have a smaller
bile pool as assessed by the bile acid content of the blood
[51]. It explains also why CYP7A1 expression does not always
negatively correlate with SHP expression [52]. More research
will be required to elucidate the interactions between produc-
tion and inactivation of toxics.4. Perturbation of the circadian clock by xenobiotics
If the impact of circadian rhythm on drug metabolism and
xenobiotic detoxiﬁcation start to be described, there is also
now evidences showing perturbations of circadian rhythm by
xenobiotics [33,53–57]. Indeed, at a molecular level, xenobiotic
exposure can signiﬁcantly alter the expression of circadian
clock genes by diﬀerent pathways; mostly AhR and PPARa
(see Table 1). By disturbing the circadian clock, and hence cir-
cadian expression of xenobiotic metabolism and transport
genes, some drugs might modify their own metabolism, and
consequently their toxicity. Hence, WY14643, a synthetic
PPARa ligand, could entrain the circadian clock by activation
of the Bmal1 promoter [53], whereas TCDD, an activator of
AhR, disrupts the circadian clock by downregulation of Per1
and Per2 expression [55].
Various other compounds that target known signaling path-
ways, such as PMA (phorbol 12-myristate 13-acetate) or for-
skolin, and are sometimes used as medical drugs can also
perturb or entrain the circadian clock [58]. In the same context,
drugs that mimic natural hormones like glucocorticoid or
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sion [59,60]. It is also interesting to mention the possible eﬀect
of retinoic acid in circadian regulation of detoxiﬁcation. Like
other drugs or hormones cited above, retinoic acid can also
interfere with the circadian clock by inactivating the
BMAL1/CLOCK or NPAS2 heterodimers after the ligand-
dependent interaction of its receptors RAR and RXR with
CLOCK or NPAS2 [61]. In addition, RXR, as heterodimeriza-
tion partner of the nuclear receptor PPARa, CAR, and PXR,
can synergically reinforced the transcriptional activity of the
heterodimer after binding of its ligand, 9-cis-retinoic acid
[62], but not always [63]. Interestingly, the concentrations of
retinoic acid and of some of its metabolites are increased after
retinoic acid administration [64] and have been found to follow
a moderate circadian rhythm in serum [65]. RXR seems thus to
play a role in the circadian rhythm of detoxiﬁcation and
administration of retinoic acid during medical treatment,
particularly of cancer [66], can both perturb circadian
rhythms and the nuclear receptor-dependent detoxiﬁcation
pathways.
In all cases, if circadian rhythms have an important impact
on drug toxicity and eﬀectiveness, the impact of drugs on cir-
cadian rhythm should be not neglected and on the other hand
can also have an inﬂuence on drug metabolism and drug/drug
deleterious interactions. By giving a rational reason to study
the interactions between circadian rhythm, administration tim-
ing of a drug and drug metabolism, studies deciphering xeno-
biotic inﬂuence on clock systems will help to deﬁne a molecular
clock-controlled pharmacology.5. Circadian clock, detoxiﬁcation and aging
It is known for decades that circadian rhythms change with
aging: absent in the newborn, they start three months after
birth, undergo changes during adolescence, stabilize in adult-
hood and deteriorated with advanced age [67,68]. As shown
in rodent, this perturbation of the circadian clock during aging
is characterized by a general alteration of the circadian expres-
sion of the circadian clock genes in the SCN and in peripheral
organs [69,70]. Interestingly, the aging-linked changes are also
described for the detoxiﬁcation capacity in both rodents and
humans [71]. This decrease in detoxiﬁcation eﬃciency seems
to be linked to a decrease in the expression of genes coding
for detoxiﬁcation enzymes and their regulators [72,73].
Whereas it has not been clearly demonstrated, some evidence
suggest that this age-dependent decrease in detoxiﬁcation is
related to the deterioration of circadian rhythms in aged peo-
ple, as circadian-regulated transcription factors play an impor-
tant role in xenobiotic detoxiﬁcation. Moreover, it has been
shown that the life span of the nematode Caenorhabditis ele-
gans is dependent of the DAF-2/Insulin growth factor receptor
pathway that was recently described to control the expression
of genes involved in many aspects of detoxiﬁcation [74].
Accordingly, a reduced activity of detoxiﬁcation genes would
be expected to promote premature aging and reduced life span,
two features shared by the PARbZip and BMal1 deﬁcient mice
[18,75]. It is likely, therefore, that age-dependent perturbations
of the circadian rhythms could be linked to the detoxiﬁcation
capacity and thus contribute to acceleration of the aging pro-
cess.6. Conclusion
Recent discoveries start to reveal the molecular mechanisms
of circadian drug metabolism. Not surprisingly, this highlights
the fact that the mechanisms involved are the same as the one
implied in the metabolism of food-contained toxic compound.
As this function is one of the major functions of circadian
rhythm in living organisms, we now start to understand the
time-dependent drug toxicity and eﬀectiveness in rodent and
human. In addition, it has been shown that xenobiotics can
perturb normal circadian rhythm by acting on circadian gene
expression. As food seems to be the major zeitgebber for most
peripheral organs [6,7], it is conceivable that food-contained
toxic compounds modulate expression of circadian clock genes
via xenobiotic-sensible transcription factors and, in turn, plays
a role in the food entrainment of the circadian oscillator. Inter-
estingly, it has been recently shown that an oscillator-indepen-
dent circadian transcription could exist, with a Heat Shock
factor 1 (HSF1)-dependent transcriptional regulation of the
mouse Per2 gene [76]. As HSF1 is known to be activated by
a wide range of stimuli including toxic compounds contained
in food [77], this possibility will have to be taken into account.
Finally, the biological consequence of xenobiotics exposure
depends on interactions between the timing of exposure and
the xenobiotic eﬀect on circadian clock machinery. The ﬁnal
goal of chronobiology is to ﬁnd the optimal time to administer
drugs in order to obtain maximum eﬃciency with minimum
doses and side-eﬀects. However, to reach this goal, we have
to better understand human circadian clock. Unfortunately,
determination of period length of circadian behavior and phys-
iology in human is costly and time consuming, and cannot be
realize by simple clinical test. Nevertheless, recent in vitro re-
sults show the relative easy recording of period length on cul-
tured primary ﬁbroblasts obtained from skin punch biopsies,
using lentiviral vectors encompassing a circadian luciferase re-
porter gene [78]. These experiments revealed a high variability
in the circadian period length between human individuals
which can possibly reﬂect genetic variations in genes control-
ling the human circadian clock. In the same time, to personal-
ize chronotherapy and obtain better adapted treatments,
knowledge of pharmacogenomics proﬁle of the patient will
be required. Genomic data acquired through the international
HapMap project will help in this attempt [79]. Interestingly,
this study revealed that the genes involved in detoxiﬁcation
are under positive and negative selection in populations with
diﬀerent diets and lifestyle, and showed that some phase
I–III drug-metabolizing enzymes are highly polymorphismic
[80]. Integration of genomic informations concerning circadian
rhythm and drug metabolism may lead to the understanding of
circadian xenobiotic detoxiﬁcation in each individual and thus
to the formulation of novel therapeutic regimens. It will be
important to take into account the perturbations of circadian
gene expression induced by xenobiotics since they can have
harmful eﬀects like increased predisposition to breast cancer
among women [81], or atherosclerosis in male-shift workers
[82], who together represent 10% of the working force across
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